- Country: Brazil
- Summary: Price Registration for the Acquisition of Cancer Drugs of Group Ix, Duly Described, Characterized and Specified in this Notice And/Or the Term of Reference, Pursuant to Law.
- BRT Ref No: 119816981
- Deadline: 05 Jun 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 90258/2025
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Object: Electronic Auction - Price Registration for the Acquisition of Cancer Medicines of Group IX, duly described, characterized and specified in this Notice and/or Reference Term, pursuant to Law.From the proposal: from 26/05/2025 to 08:00
zoledronic acid, 4 mg concentration, pharmaceutical form lipophyl powder p/injectable
quantity: 470
quantity: 3240
quantity: 360
axitinib, concentration 5 mg
quantity: 2268
axitinib,Concentration 5 mg
Quantity: 252
bicalutamide, dosage 50 mg
quantity: 80860
Bleomycin sulfate, concentration 15 u, pharmaceutical form lipyl powder for injectable
quantity: 60
cabazitaxel, concentration 40 mg/ ml, pharmaceutical form injectable solution
quantity: 30
carboplatin, dosage 150 mg,Use injectable
quantity: 100
carboplatin, dosage 450 mg, injectable use
quantity: 675
carboplatin, dosage 450 mg, injectable use
quantity: 75
cetuximab, concentration 5 mg/ml, pharmaceutical form injectable solution
quantity: 603
cetuximab, concentration 5 mg/ml, pharmaceutical formInjectable
Quantity: 67
cyclophosphamid, concentration 1 g, pharmaceutical form lipyl powder for injectable
quantity: 400
cisplatin, concentration 50 mg, pharmaceutical form lipophyl powder for injectable
quantity: 210
dacarbazine, concentration 200 mg, injectable use
quantity, 40
docaetaxel, concentration20 mg/ml, injectable pharmaceutical form
Quantity: 160
Docetaxel, concentration 40 mg/ml, injectable pharmaceutical form
Quantity: 720
Doxorrubicin hydrochloride, dosage 2 mg/ml, injectable indication, characteristic liposomal pissed
quantity: 70
doxorubicine chloride, dosage 50Mg, injectable indication
... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINPrice Registration for the Acquisition of Cancer Drugs of Group Ix, Duly Described, Characterized and Specified in this Notice And/Or the Term of Reference, Pursuant to Law. - Brazil Tender
The CITY HALL OF RIO DE JANEIRO, a Government sector organization in Brazil, has announced a new tender for Price Registration for the Acquisition of Cancer Drugs of Group Ix, Duly Described, Characterized and Specified in this Notice And/Or the Term of Reference, Pursuant to Law.. This tender is published on BrazilTenders under BRT Ref No: 119816981 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-06-05.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
